跳至主要内容
临床试验/NCT02805803
NCT02805803招募中不适用

Quality of Life Assessment in Patients Undergoing Prolonged Suppressive Antibiotherapy for Prosthetic Joint Infection.

Groupe Hospitalier Diaconesses Croix Saint-Simon4 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2016年11月9日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60
试验地点
4
主要终点
Quality of life assessment of patients undergoing prolonged suppressive antibiotherapy for PJI.

研究概览

简要总结

Prosthetic joint infection (PJI) management is complex and requires prosthesis replacement when symptoms duration is greater than 30 days or debridement with modular set replacement when symptoms duration is lesser than one month. Nevertheless, the prolonged suppressive antibiotherapy (PSA) is the single treatment we can provide to high risk surgical patients and those who refuse reoperation.

There is limited data available on PSA modality, its tolerance and efficacy, this lack of data motivated us to concept a prospective study of long term patient follow up with PJI treated with prolonged suppressive antibiotherapy.

详细描述

Main objective:

Quality of life assessment of patients undergoing prolonged suppressive antibiotherapy for PJI.

Secondary objectives:

  1. Depressive symptoms assessment in patients undergoing prolonged suppressive antibiotherapy for PJI.
  2. Functional assessment in patients undergoing prolonged suppressive antibiotherapy for PJI.
  3. Evaluation of PSA side effects
  4. Evaluation of nutritional status
  5. Evaluation of of PSA termination criteria

Methods:

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient aged over 18 years old with hip or knee prosthetic infection who consented to participate in the study
  • Non-eligible patient to surgical treatment
  • Patient eligible to prolonged suppressive antibiotherapy

排除标准

  • patient who does not meet eligibility criteria
  • Patient living or traveling abroad for whom 2 years minimum follow up is impossible.
  • Patient lawfully deprived of his liberty
  • Patient not insured under social security scheme

结局指标

主要结局

Quality of life assessment of patients undergoing prolonged suppressive antibiotherapy for PJI.

时间窗: 2 years

Method assessment : Short Form 12 questionary (SF12)

次要结局

  • 3. Evaluation of PSA side effects(2 years)
  • 4. Evaluation of nutritional status(2 years)
  • 5. Evaluation of PSA termination criteria(2 years)
  • 2. Functional assessment in patients undergoing prolonged suppressive antibiotherapy for PJI.(2 years)
  • 1. Depressive symptoms assessment in patients undergoing prolonged suppressive antibiotherapy for PJI.(2 years)

研究者

发起方
Groupe Hospitalier Diaconesses Croix Saint-Simon
申办方类型
Other
责任方
Principal Investigator
主要研究者

SMARMOR

Director

Groupe Hospitalier Diaconesses Croix Saint-Simon

研究点 (4)

Loading locations...

相似试验